Literature DB >> 10403701

The genome of cowpox virus contains a gene related to those encoding the epidermal growth factor, transforming growth factor alpha and vaccinia growth factor.

F G da Fonseca1, R L Silva, J T Marques, P C Ferreira, E G Kroon.   

Abstract

Cowpox virus (CPV) is a member of the Orthopoxvirus genus and has the genetic capacity to encode a multitude of genes that interfere with the host inflammatory and immune response or modulate the physiological state of infected and non-infected cells. Among these CPV factors are receptors homologous to interferon and tumor necrosis factor receptors and also a viral cellular serine-proteinase analog. Here we describe the detection of a CPV gene that encodes a protein homologous to epidermal growth factor, transforming growth factor alpha and poxvirus growth factors, such as the vaccinia growth factor (VGF). The VGF and other poxvirus growth factors are produced early in the infection and are secreted into the medium where they bind to the EGF receptors, generating mytotic responses. The cowpox growth factor (CGF) gene was detected in three copies on the virus genome by PCR, and by northern and southern blot hybridization using VGF nucleotide sequences as primers and probes. The CPV gene has a strong nucleotide and predicted amino acid similarity with VGF, and is also produced early in the infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403701     DOI: 10.1023/a:1008072720217

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  57 in total

1.  The UL20 gene of herpes simplex virus 1 encodes a function necessary for viral egress.

Authors:  J D Baines; P L Ward; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP.

Authors:  K L Pogue-Geile; P G Spear
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

3.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

4.  Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells.

Authors:  D C Johnson; P G Spear
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

5.  Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivo.

Authors:  B P Randazzo; J C Kucharczuk; L A Litzky; L R Kaiser; S M Brown; A MacLean; S M Albelda; N W Fraser
Journal:  Virology       Date:  1996-09-15       Impact factor: 3.616

6.  Role of the Na+,K+ pump in herpes simplex type 1-induced cell fusion: melittin causes specific reversion of syncytial mutants with the syn1 mutation to Syn+ (wild-type) phenotype.

Authors:  A Baghian; K G Kousoulas
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

7.  Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.

Authors:  J Rajcáni; A Sabó; V Mucha; M Kostál; P Compel
Journal:  Acta Virol       Date:  1995-02       Impact factor: 1.162

8.  Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface.

Authors:  L Hutchinson; C Roop-Beauchamp; D C Johnson
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.

Authors:  J W Dick; K S Rosenthal
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.

Authors:  M W Ligas; D C Johnson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  8 in total

1.  Down-regulation of p53 by double-stranded RNA modulates the antiviral response.

Authors:  Joao T Marques; Dominique Rebouillat; Chilakamarti V Ramana; Junko Murakami; Jason E Hill; Andrei Gudkov; Robert H Silverman; George R Stark; Bryan R G Williams
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells.

Authors:  David Jeng; Zhenzhong Ma; John W Barrett; Grant McFadden; Jeffrey A Loeb; Karim Essani
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 3.  Modulation of the host immune response by cowpox virus.

Authors:  Dina Alzhanova; Klaus Früh
Journal:  Microbes Infect       Date:  2010-07-29       Impact factor: 2.700

4.  Chasing Jenner's vaccine: revisiting cowpox virus classification.

Authors:  Darin S Carroll; Ginny L Emerson; Yu Li; Scott Sammons; Victoria Olson; Michael Frace; Yoshinori Nakazawa; Claus Peter Czerny; Morten Tryland; Jolanta Kolodziejek; Norbert Nowotny; Melissa Olsen-Rasmussen; Marina Khristova; Dhwani Govil; Kevin Karem; Inger K Damon; Hermann Meyer
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

5.  Predicting the subcellular localization of viral proteins within a mammalian host cell.

Authors:  M S Scott; R Oomen; D Y Thomas; M T Hallett
Journal:  Virol J       Date:  2006-04-04       Impact factor: 4.099

Review 6.  Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections.

Authors:  Cathleen R Carlin
Journal:  Front Cell Infect Microbiol       Date:  2022-01-10       Impact factor: 5.293

7.  ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.

Authors:  Yuriko Iwakura; Hiroyuki Nawa
Journal:  Front Cell Neurosci       Date:  2013-02-13       Impact factor: 5.505

8.  Passatempo virus, a vaccinia virus strain, Brazil.

Authors:  Juliana A Leite; Betânia P Drumond; Giliane S Trindade; Zélia I P Lobato; Flávio G da Fonseca; Santos João R dos; Marieta C Madureira; Maria I M C Guedes; Jaqueline M S Ferreira; Cláudio A Bonjardim; Paulo C P Ferreira; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.